Pricing Log in Create free account

Aurora Cannabis Inc. (ACB) vs Evotec AG (EVO)

Aurora Cannabis Inc. and Evotec AG are both Drug Manufacturers Specialty & Generic companies. Evotec AG is the larger, with a market value of $630.4M against $341.2M — 1.8× the size. Evotec AG grew revenue faster over the last twelve months: 2.15% against −18.2%. Evotec AG has the higher net margin (−26.2% vs −38.1%) and the higher return on invested capital (0.00% vs −5.58%). Across the 18 metrics below, Evotec AG leads on 12 and Aurora Cannabis Inc. on 6.

Valuation

Metric ACB EVO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.53 0.72 2.08
P/B 0.84 0.81 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.28 0.74 2.87
Earnings yield (27.12%) (36.25%) (15.94%)
Free cash flow yield (11.26%) (32.04%) 0.00%

Profitability

Metric ACB EVO Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 11.42% 53.51%
Operating margin (12.13%) (21.35%) 0.00%
Net margin (38.12%) (26.20%) (2.45%)
Free cash flow margin (17.19%) 0.00% 0.00%
Return on equity (19.85%) 0.00% (0.80%)
Return on assets (15.19%) 0.00% (1.67%)
Return on invested capital (5.58%) 0.00% 0.00%

Growth

Metric ACB EVO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) 2.15% 5.22%
EPS growth (last fiscal year) (5,266.67%) 44.89% 42.91%
Revenue growth, 5-year CAGR 3.92% 9.28% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACB EVO Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 0.72 0.04
Current ratio 5.36 2.33 2.41
Net debt to EBITDA 5.11 (0.64) 1.01

Dividend

Metric ACB EVO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ACB EVO Drug Manufacturers Specialty & Generic median
Market cap 341.19m 630.44m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack